Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.13B |
| 2 |
Eaton
ETN
|
+$1.11B |
| 3 |
Analog Devices
ADI
|
+$867M |
| 4 |
Progressive
PGR
|
+$792M |
| 5 |
Datadog
DDOG
|
+$693M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$1.7B |
| 2 |
NVIDIA
NVDA
|
+$1.45B |
| 3 |
Salesforce
CRM
|
+$1.22B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.2B |
| 5 |
lululemon athletica
LULU
|
+$1.11B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 39.74% |
| 2 | Consumer Discretionary | 15.53% |
| 3 | Communication Services | 13.54% |
| 4 | Healthcare | 12.18% |
| 5 | Financials | 8.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Alcoa
AA
$11.9B
| $15.1M | 0.01% |
380,033
+233,580
| +159% | +$9.04M |
|
352
CAVA Group
CAVA
$7.6B
| $14.9M | 0.01% |
160,864
-444,971
| -73% | -$34.3M |
|
353
Texas Instruments
TXN
$252B
| $14.7M | 0.01% |
75,614
-38,738
| -34% | -$7.16M |
|
354
Atlantic Union Bankshares
AUB
$6.02B
| $14.6M | 0.01% |
443,150
+125,045
| +39% | +$4.08M |
|
|
TRML
355
DELISTED
Tourmaline Bio
TRML
| $14.5M | 0.01% |
1,127,691
+12,440
| +1% | +$200K |
|
356
XP
XP
$8.81B
| $14.5M | 0.01% |
821,991
-2,291,163
| -74% | -$47.3M |
|
357
IDEAYA Biosciences
IDYA
$3.42B
| $14.4M | 0.01% |
410,862
+154,613
| +60% | +$6.12M |
|
358
Twist Bioscience
TWST
$5.7B
| $14.4M | 0.01% |
291,495
+141,473
| +94% | +$5.77M |
|
359
Guardant Health
GH
$21.7B
| $14.4M | 0.01% |
497,088
+7,431
| +2% | +$173K |
|
360
Penumbra
PEN
$12.7B
| $13M | 0.01% |
72,464
-14,675
| -17% | -$2.93M |
|
|
FL
361
DELISTED
Foot Locker
FL
| $12.9M | 0.01% |
+519,650
| New | +$12.4M |
|
362
Kymera Therapeutics
KYMR
$8.51B
| $12.8M | 0.01% |
429,287
+3,367
| +0.8% | +$117K |
|
363
Marcus & Millichap
MMI
$1.16B
| $12.7M | 0.01% |
401,530
+2,877
| +0.7% | +$93.1K |
|
364
Vertex
VERX
$2.09B
| $12.5M | 0.01% |
+345,357
| New | +$11.1M |
|
365
Structure Therapeutics
GPCR
$3.41B
| $12.4M | 0.01% |
+314,503
| New | +$12.9M |
|
366
BJs Wholesale Club
BJ
$12.5B
| $12.3M | 0.01% |
+140,155
| New | +$11.4M |
|
367
Insulet
PODD
$11.5B
| $12.3M | 0.01% |
60,787
-19,200
| -24% | -$3.46M |
|
368
Northern Oil and Gas
NOG
$2.3B
| $12.2M | 0.01% |
328,576
+132,518
| +68% | +$5.31M |
|
369
Freeport-McMoran
FCX
$90B
| $12M | 0.01% |
247,851
+745
| +0.3% | +$37.5K |
|
370
Apogee Therapeutics
APGE
$10.1B
| $12M | 0.01% |
306,078
+3,186
| +1% | +$155K |
|
|
MRX
371
Marex Group Limited Ordinary Shares
MRX
$4.67B
| $11.9M | 0.01% |
+596,851
| New | +$11.7M |
|
372
RBC Bearings
RBC
$17.4B
| $11.8M | 0.01% |
43,766
+472
| +1% | +$127K |
|
373
Evolent Health
EVH
$348M
| $11.7M | 0.01% |
+611,816
| New | +$15.6M |
|
374
Nike
NKE
$61.9B
| $11.6M | 0.01% |
154,518
-8,705,062
| -98% | -$809M |
|
375
Corteva
CTVA
$52.6B
| $11.6M | 0.01% |
214,399
+197
| +0.1% | +$10.8K |
|
Similar funds
Jennison Associates's Q2 2024 Portfolio in Review
As of Q2 2024, Jennison Associates held 620 positions worth $156B, up 4.3% from $150B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Jennison Associates's Q2 2024 filing shows 48 new, 288 increased, 229 reduced and 48 closed positions. Its largest new stake was Analog Devices: 4,062,204 shares worth $927M. The largest sale was UnitedHealth, an estimated $1.7B.
By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 39% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Jennison Associates's largest Q2 2024 buy was Analog Devices: 4,062,204 shares worth $927M.
- Jennison Associates added most to Apple in Q2 2024, an estimated $2.13B increase.
- Jennison Associates's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $1.7B.
- Jennison Associates fully exited Estee Lauder in Q2 2024, selling an estimated $291M.
- Jennison Associates's ten largest holdings make up 48% of its $156B portfolio in Q2 2024.
- Jennison Associates opened 48 new positions and closed 48 in Q2 2024.
- Jennison Associates's portfolio value rose 4.3% quarter-over-quarter to $156B.
Based on Jennison Associates's 13F filing for Q2 2024, filed 5 Aug 2024.